Firefly Neuroscience (AIFF) Other Non Operating Income (2010 - 2026)
Firefly Neuroscience (AIFF) posted Other Non Operating Income of -$45000.0 for Q2 2026, down 4400.0% on a QoQ basis from -$1000.0 in Q1 2026, and up 77.83% year-over-year from -$25304.7 in Q2 2025.
Analysis
Firefly Neuroscience (AIFF) Other Non Operating Income (2010 - 2026) Analysis & Trends
Firefly Neuroscience has reported Other Non Operating Income for 16 years, with the latest figure at -$45000.0 in Q2 2026.
- On a quarterly basis, Other Non Operating Income rose 77.83% year-over-year to -$45000.0 in Q2 2026; TTM through Jun 2026 was -$48000.0, a 99.5% increase from a year earlier, with the FY2025 full-year figure at -$9.4 million, down 4831.05% from the prior year.
- Other Non Operating Income was -$45000.0 for Q2 2026 at Firefly Neuroscience, down from -$1000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $459000.0 in Q4 2023, with the low at -$9.4 million in Q1 2025.
- Average Other Non Operating Income over 5 years is -$611511.4, with a median of $91.0 recorded in 2023.
- The sharpest annual moves came in 2024 and 2025: Other Non Operating Income surged 23564.12% in 2024, then slumped 33360.71% in 2025.
- Over 5 years, Other Non Operating Income stood at $3130.0 in 2022, then soared by 14564.54% to $459000.0 in 2023, then plunged by 104.79% to -$22000.0 in 2024, then soared by 90.91% to -$2000.0 in 2025, then sank by 2150.0% to -$45000.0 in 2026.
- The last three Other Non Operating Income figures came in at -$45000.0 (Q2 2026), -$1000.0 (Q1 2026), and -$2000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn |
| 10 | Firefly Neuroscience | 23.25 Mn | 14.03 Mn | 253,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -45,000.00 |
| Mar 31, 2026 | -1,000.00 |
| Sep 30, 2025 | -2,000.00 |
| Jun 30, 2025 | -203,000.00 |
| Mar 31, 2025 | -9.37 Mn |
| Sep 30, 2024 | -22,000.00 |
| Jun 30, 2024 | 31,000.00 |
| Mar 31, 2024 | -28,000.00 |
| Dec 31, 2023 | 459,000.00 |
| Jun 30, 2023 | 131.00 |
| Mar 31, 2023 | 91.00 |
| Dec 31, 2022 | 3,130.00 |
| Sep 30, 2022 | 3,188.00 |
| Jun 30, 2022 | 195.00 |
| Mar 31, 2022 | 594.00 |
| Dec 31, 2021 | 438,400.00 |
| Sep 30, 2021 | 3,795.00 |
| Jun 30, 2021 | 4,404.00 |
| Mar 31, 2021 | 3,404.00 |
| Dec 31, 2020 | 3,762.00 |